| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,313 |
2,867 |
$380K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,521 |
1,519 |
$188K |
| S9083 |
Global fee urgent care centers |
464 |
391 |
$39K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
88 |
86 |
$9K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
130 |
130 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
74 |
71 |
$2K |
| 99051 |
|
872 |
842 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
460 |
451 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
47 |
30 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
110 |
101 |
$813.20 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
30 |
$346.50 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
95 |
95 |
$339.66 |
| 99201 |
|
13 |
13 |
$267.02 |
| 36415 |
Collection of venous blood by venipuncture |
55 |
54 |
$1.08 |
| 99050 |
|
169 |
156 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
13 |
13 |
$0.00 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
20 |
$0.00 |